Your browser doesn't support javascript.
loading
[The efficacy and safety profile of ixazomib/lenalidomide/dexamethasone in relapsed/refractory multiple myeloma: a multicenter real-world study in China].
Yang, Y; Xia, Z J; Zhang, W H; Fu, C C; Bao, L; Chen, B; Ding, K Y; Wang, S L; Luo, J; Li, B Z; Hua, L M; Yang, W; Zhou, X; Wang, L; Xu, T H; Wang, W D; Wu, G L; Huang, Y; Li, J; Liu, P.
Afiliación
  • Yang Y; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Xia ZJ; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Zhang WH; Department of Hematology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.
  • Fu CC; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 210056, China.
  • Bao L; Department of Hematology, Beijing Jishuitan Hospital, Beijing 100035, China.
  • Chen B; Department of Hematology, The Affiliated Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, China.
  • Ding KY; Department of Hematology, Anhui Provincial Cancer Hospital, Hefei 230031, China.
  • Wang SL; Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
  • Luo J; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
  • Li BZ; Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Hua LM; Department of Hematology, The Affiliated Hospital of Hebei University, Baoding 071030, China.
  • Yang W; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
  • Zhou X; Department of Hematology, Wuxi People Hospital, Wuxi 214023, China.
  • Wang L; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou 510280, China.
  • Xu TH; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Wang WD; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Wu GL; Department of Hematology, Anhui Provincial Cancer Hospital, Hefei 230031, China.
  • Huang Y; Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
  • Li J; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Liu P; Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Xue Ye Xue Za Zhi ; 42(8): 628-634, 2021 Aug 14.
Article en Zh | MEDLINE | ID: mdl-34547867
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Aged / Humans País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Aged / Humans País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2021 Tipo del documento: Article País de afiliación: China